Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801021 · ClinicalTrials.gov registry record · Phase 1
Treatment and/or Prevention of Urinary Tract Infections
A Phase 1 study of Urinary Tract Infections and Cystitis, sponsored by Biomedical Development Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT00801021: Completed Phase 1 study of Urinary Tract Infections and Cystitis, sponsored by Biomedical Development Corporation.
NCT00801021 is a Phase 1 study of Urinary Tract Infections and Cystitis that has completed, run by Biomedical Development Corporation. The registered enrollment target is 3 participants, below the 458-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00801021, a Phase 1 study of Urinary Tract Infections and Cystitis, has completed, sponsored by Biomedical Development Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine the effect of an investigational oral rinse in reducing uropathogens and treating uncomplicated urinary tract infections.
Conditions Studied
Interventions
- DRUG Frio Mouth Rinse
Study Locations (1)
Texas
- Ben Taub General Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
What the finished NCT00801021 record still lists
NCT00801021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 458-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 1 intervention - of which Frio Mouth Rinse is the first listed.
NCT00801021 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00801021 about?
NCT00801021 is a clinical study titled "Treatment and/or Prevention of Urinary Tract Infections". The purpose of the study is to determine the effect of an investigational oral rinse in reducing uropathogens and treating uncomplicated urinary tract infections.
What is the current status of trial NCT00801021?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-12. Estimated completion is 2009-06.
What conditions does trial NCT00801021 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Cystitis.
What interventions are being tested in trial NCT00801021?
The interventions under investigation include: Frio Mouth Rinse (DRUG).
Who is sponsoring clinical trial NCT00801021?
This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801021 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00801021's enrollment target sits among peer trials
3 35th of 34 the lowest of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection
COMPLETED · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia